Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
28.17
-0.30 (-1.04%)
Mar 31, 2025, 9:51 AM EDT - Market open
Amphastar Pharmaceuticals Revenue
In the year 2024, Amphastar Pharmaceuticals had annual revenue of $731.97M with 13.59% growth. Amphastar Pharmaceuticals had revenue of $186.52M in the quarter ending December 31, 2024, with 4.73% growth.
Revenue (ttm)
$731.97M
Revenue Growth
+13.59%
P/S Ratio
1.88
Revenue / Employee
$360,930
Employees
2,028
Market Cap
1.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 731.97M | 87.57M | 13.59% |
| Dec 31, 2023 | 644.40M | 145.41M | 29.14% |
| Dec 31, 2022 | 498.99M | 61.22M | 13.98% |
| Dec 31, 2021 | 437.77M | 87.92M | 25.13% |
| Dec 31, 2020 | 349.85M | 27.49M | 8.53% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
AMPH News
- 3 days ago - International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award - Accesswire
- 26 days ago - Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference - Accesswire
- 4 weeks ago - Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds - Benzinga
- 4 weeks ago - Amphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024 - Accesswire
- 5 weeks ago - Top 2 Health Care Stocks That May Rocket Higher This Month - Benzinga
- 5 weeks ago - Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025 - Accesswire
- 5 weeks ago - Amphastar Pharmaceuticals: A Gradual Strategy - Seeking Alpha